Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Dec:25:1.
doi: 10.7812/TPP/20.189.

Digital Communication Technology: Does Offering a Choice of Modality Improve Medication Adherence and Outcomes in a Persistent Asthma Population?

P J Cvietusa  1   2 , N M Wagner  1 , J A Shoup  1 , G K Goodrich  1 , S M Shetterly  1 , D K King  3 , M A Raebel  1 , C S Riggs  4 , B Bender  5
Affiliations
Randomized Controlled Trial

Digital Communication Technology: Does Offering a Choice of Modality Improve Medication Adherence and Outcomes in a Persistent Asthma Population?

P J Cvietusa et al. Perm J. 2020 Dec.

Abstract

Background: Use of digital communication technology has shown potential to improve asthma adherence and outcomes. Few studies have looked at patient preference around mode of medication reminders used to improve and maintain asthma medication adherence.

Objective: To determine if, in a population already receiving automated medication reminders, offering a choice for preferred mode of reminder (text, email, phone) would improve their adherence and asthma outcomes over a 1-year period.

Methods: This was a pragmatic, randomized controlled trial conducted at Kaiser Permanente Colorado involving 7522 adult patients with persistent asthma. Study patients were randomized to receive usual care or their choice of medication reminder. Differences between the 2 groups in both medication adherence and asthma outcomes were then assessed over the following year.

Results: Only 30% of those offered a choice of medication reminder modality responded by making a choice, with 52% preferring text messaging. There was less of a decrease in adherence rate over the 1-year period in those who made a choice regarding the mode of medication refill reminder. There was no difference in asthma outcomes between those who did make a choice compared with those who did not make a choice regarding the mode of medication refill reminder.

Conclusion: In a patient population already receiving medication reminders, offering a choice about what type of technology-enabled asthma medication reminder patients wanted did not improve outcomes but did enable a subgroup to better maintain their medication adherence.

Trial registration: ClinicalTrials.gov NCT02761837.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement: The author(s) have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Breathewell study patients and preferences for inhaled corticosteroid refill reminders.
See this image and copyright information in PMC

References

    1. Licari A, Ferrante G, Marseglia GL, Corsello G, La Grutta S. What is the impact of innovative electronic health interventions in improving treatment adherence in asthma? The pediatric perspective. J Allergy Clin Immunol Pract 2019 Nov-Dec;7(8):2574-9. DOI: 10.1016/j.jaip.2019.08.008, PMID:31425835 - DOI - PubMed
    1. Blakey JD, Bender BG, Dima AL, Weinman J, Safioti G, Costello RW. Digital technologies and adherence in respiratory diseases: The road ahead. Eur Respir J 2018 Nov;52(5):1801147. DOI: 10.1183/13993003.01147-2018, PMID:30409819 - DOI - PMC - PubMed
    1. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: WHO; 2003.
    1. McQuaid EL. Barriers to medication adherence in asthma: The importance of culture and context. Ann Allergy Asthma Immunol 2018 Jul;121(1):37-42. DOI: 10.1016/j.anai.2018.03.024, PMID:29580846 - DOI - PubMed
    1. Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 2008 Jul;33(6):590-611. DOI: 10.1093/jpepsy/jsm128, PMID:18192300 - DOI - PubMed

Publication types

Associated data